scorecard

You Searched For "innovation in biotech" and got 20 results


Sort By:


Business Insider Latest Story Image
2 mins read

Covaxin shows 77.8% effectiveness against symptomatic COVID-19 cases in phase-3 trials

The efficacy analysis demonstrates Covaxin to be 93.4 per cent effective against severe symptoma…

PTI   


Business Insider Latest Story Image
4 mins read

Men fill more than 9 in 10 biopharma CEO positions, an inequity that costs women more than $500 million in pay each year

Despite more attention being paid to diversity efforts, 92% of top biopharma CEOs are men, an Insid…

Shelby Livingston,Andrew Dunn   


Business Insider Latest Story Image
3 mins read

Covaxin supply to government at ₹150 per dose is not sustainable, says Bharat Biotech

The supply price of Covaxin to the government of India at Rs 150 a dose is a non-competitive price …

Business Insider Latest Story Image
3 mins read

Novavax says its coronavirus vaccine was 90% effective in a large trial, moving the shot a step closer to widespread use

Novavax fell behind rivals like Pfizer and Moderna, and the biotech's launch timeline remains hazy.

Andrew Dunn   


Lydia Ramsey Pflanzer   


Business Insider Latest Story Image
1 min read

Bharat Biotech inks deal to supply Covaxin to Brazil

Hyderabad, Jan 12 (IANS) Bharat Biotech on Tuesday announced it has signed an agreement with Precis…

Business Insider Latest Story Image
1 min read

Covaxin priced at ₹600 and ₹1200 for state and private hospitals respectively

The company also revealed that Covaxin’s export prices have been set at $15-$20. In a stateme…

PTI   


Business Insider Latest Story Image
6 mins read

How 4 US cities are building resilience by focusing on clean energy, innovation, and smart infrastructure

Insider highlighted Honolulu, San Antonio, Boston, and Raleigh-Durham as cities striving to be more…

Erica Sweeney   


Business Insider Latest Story Image
2 mins read

KemPharm skyrockets 90% after FDA approval of ADHD treatment

KemPharm stock skyrocketed on Wednesday after the FDA approved the company's once-daily treatment f…

Will Daniel   


Business Insider Latest Story Image
1 min read

Bharat Biotech claims its Covid 19 vaccine Covaxin will work against UK strain

Hyderabad-based Bharat Biotech said on Monday that its vaccine is efficient against the mutant stra…

Business Insider Latest Story Image
1 min read

Bharat Biotech dispatches 1st batch of Covaxin for immunisation drive

New Delhi, Jan 4 (IANS) Hyderabad-based Bharat Biotech has sent the first batch of its Covid vaccin…

Business Insider Latest Story Image
1 min read

Covaxin can deal with new Covid strains too: Bharat Biotech

Hyderabad, Dec 30 (IANS) Bharat Biotech said on Tuesday that its vaccine candidate, Covaxin, will b…

Business Insider Latest Story Image
5 mins read

Hyderabad : Vaccine capital of the world

This southern city, already recognised as a global information technology destination, proved …

Business Insider Latest Story Image
2 mins read

India's first vaccine candidate - Bharat Biotech's Covaxin begins its Phase-3 trials

Hyderabad, Nov (IANS) Vaccine maker Bharat Biotech on Monday announced that it has commenced Phase-…

Business Insider Latest Story Image
1 min read

IIT-Kharagpur shows how to innovate, bags maximum laurels at innovation awards

"After four rounds of evaluation, 19 teams have been selected for innovation awards and 24 for appr…

Business Insider Latest Story Image
4 mins read

The election's consequences for digital health

These are the top stories written by Business Insider's healthcare team for the week ending October…

Blake Dodge   


Business Insider Latest Story Image
2 mins read

Bharat Biotech partners with Washington varsity for intranasal COVID-19 vaccine

The Hyderabad-based company owns the rights to distribute the vaccine in all markets except USA,…

Business Insider Latest Story Image
2 mins read

Novavax soars 13% after inking deal with UK for 60 million doses of coronavirus vaccine

The UK government will collaborate with Novavax on phase 3 trials of its NVX-CoV2373 vaccine, accor…

Ben Winck   


Business Insider Latest Story Image
2 mins read

Billionaire investor Chamath Palihapitiya files for 4 new biotech-focused SPACs that seek to raise $800 million

The latest additions build on Palihapitiya's roster of 6 special-purpose acquisition companies alre…

Shalini Nagarajan   


Business Insider Latest Story Image
2 mins read

UK biotech firm skyrockets 552% after drug lowers odds of serious COVID-19 symptoms

The probability of a patient receiving the drug to require ventilation or die dropped 79% compared …

Ben Winck